Data from two studies presented at the Congress of the European Renal Association and European Dialysis and Transplant Association showed positive results for Baxter's HDx therapy using the Theranova dialyzer. One of the studies showed removal rates demonstrated by the HDx therapy for small and medium molecules were comparable to those of high-volume hemodiafiltration treatments, while the other study showed that four kidney failure-related molecules were cleared by the HDx therapy to a similar extent as the HDF treatment.
Data show positive results for Baxter's HDx therapy with Theranova dialyzer
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.